Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC and Simethicone for Mucosal Visibility in Upper GI Endoscopy
NCT07245095Phase 2Recruiting
- Sponsor
- Hospital General de Mexicali
- Start
- Sep 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine, simethicone in esophagogastroduodenoscopy, sponsored by Hospital General de Mexicali. Started Sep 2025; status: recruiting.
02
Drugs
acetylcysteinesimethicone
03
Conditions
esophagogastroduodenoscopy
Beyond the preview
Go deeper on NCT07245095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07245095.